Acarbose

This product is an oral hypoglycemic drug. Its hypoglycemic mechanism is to inhibit the competition between small intestinal wall cells and oligosaccharides, and reversibly bind to glucosidase to inhibit the activity of the enzyme, thereby delaying the degradation of carbohydrates, causing slow intestinal glucose absorption, and reducing the increase in postprandial blood sugar.

Acarbose

Combined with diet control to treat type 2 diabetes.

Swallow the whole tablet immediately before eating or chew it with the first few bites of food. The dosage varies from person to person. The generally recommended dosage is: the starting dose is 50 mg each time, 3 times a day. Then gradually increase to 0.1 g each time, 3 times a day. In some cases, it can be increased to 0.2 g each time, 3 times a day. Or follow the doctor's advice.

There is often flatulence and bowel sounds, occasional diarrhea, and rarely abdominal pain. If the diet is not controlled, gastrointestinal side effects may be aggravated. If severe discomfort still occurs after controlling the diet, consult a doctor to reduce the dose temporarily or permanently. In some cases, skin allergic reactions such as erythema, rash, and urticaria may occur.

1. It is contraindicated for patients who are allergic to acarbose; 2. It is contraindicated for patients with diabetic coma or pre-coma, acidosis or ketosis; 3. It is contraindicated for patients with chronic gastrointestinal dysfunction with obvious digestive and absorption disorders; 4. It is contraindicated for patients with diseases that may be aggravated by intestinal flatulence (such as Roemheld syndrome, severe hernia, intestinal obstruction, intestinal surgery and intestinal ulcer); 5. It is contraindicated for patients with severe liver and kidney damage; 6. It should be used with caution in pregnant and lactating women; 7. It should be used with caution in patients under 18 years old.

Precautions for children: Use with caution in patients under 18 years of age. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women.

1. If this product is used together with sulfonylureas, metformin or insulin, blood sugar may drop to the level of hypoglycemia, and the dosage of sulfonylureas, metformin or insulin needs to be reduced. 2. During the period of taking this product, avoid taking antacids, cholestyramine, intestinal adsorbents and digestive enzyme preparations at the same time to avoid affecting the efficacy of this product. 3. Taking neomycin at the same time can further reduce blood sugar after meals and aggravate the gastrointestinal reaction of this product.

Shade, seal, and keep in a cool place

－－－－

24 months

Livzon New North River Pharmaceutical Co., Ltd.

• Founded in:

  1993-03-28

• Address:

  Renmin 1st Road, Qingyuan City, Guangdong Province

• Tax NO.:

  91441800617971683E

• Registered Funds:

  239.8877 million yuan

• Website:

  Log in to view

• Email:

  Log in to view